“Viral respiratory and neurologic diseases are the leading preventable causes of death in horses,” said Jacquelin Boggs, DVM, MS, ACVIM, senior veterinarian, Equine Technical Services at Zoetis. “While annual vaccination against the core equine diseases has long been an established standard of care, Core EQ Innovator will simplify compliance and help provide protection to all horses against these deadly diseases. We trust this vaccine will better equip veterinarians with the tools they need to help protect the health and well-being of horses.”
Core EQ Innovator provides a safe and effective immune response against the five core equine disease antigens as demonstrated in safety and efficacy trials. The vaccine has been field tested in more than 1,000 horses with 99.7 percent of horses being reaction-free.2,3 With a convenient 1-mL dose size, the vaccine is safe for use in healthy horses 3 months of age or older.
All of the disease antigens in Core EQ Innovator are backed by the Zoetis Equine Immunization Support Guarantee. The guarantee provides horse owners and veterinarians peace of mind through unparalleled vaccination support, including diagnostic testing and treatment.
The addition of Core EQ Innovator enriches the best-in-class portfolio of equine vaccines from Zoetis. Core EQ Innovator will be available to veterinarians through their Zoetis representative and distribution partners. Horse owners are encouraged to contact their veterinarian for more information or visit CoreEQInnovator.com.